High pressure was applied to recombinant human lactoferrin obtained from rice (rhLF) and its effect was evaluated on the structure and activity of the protein.
Heat treatment is a traditional technique used to preserve many foods by inactivating foodborne pathogens and spoilage bacteria, but it causes modifications in the nutritional and sensorial characteristics of food, affecting its overall quality. Heating produces changes in processed foods, including alterations in flavor and color, especially when treatment consists of high temperature for a long period of time. [1] [2] [3] High hydrostatic pressure (HHP), an emerging technology for food processing as a non-thermal method, is being investigated to replace heat treatment in the processing of certain products. High pressure treatment can be conducted at low temperatures and even under refrigeration, and hence food products do not suffer from heat damage, and are of higher nutritional and sensorial quality than their thermally treated counterparts. 4) HHP processing can be applied from 100 to 900 MPa to food, though in commercial systems the pressure applied is normally between 300 and 700 MPa, with water as the usual pressure transmitting medium. 5) High-pressure technology has proven practical applications, as it reduces the load of pathogenic agents. 6) Treatment with high pressure can be combined with other treatments or agents for food preservation. This form of preservation, combining different strategies, has been defined as hurdle technology. 7) This technology is designed to maintain nutritive and organoleptic characteristics closer to those of non-treated foods. Natural antimicrobial agents are among these additional hurdles, and they can impair the equilibrium of bacteria, making them more susceptible to the effects of non-thermal methods. 7) Some of these natural antimicrobial compounds are produced by lactic acid bacteria, including bacteriocins, 8) some are present in plants, including essential oils, 9) and others are present in milk secretions. Milk contains several proteins that constitute a nonspecific defense system against microorganisms, lactoperoxidase and lactoferrin being the most representative. 10, 11) Those two proteins have different antibacterial mechanisms and are used for different purposes, lactoferrin in functional products and lactoperoxidase to preserve milk before heat treatment, in countries with poor hygienic conditions of storage.
Lactoferrin is an iron-binding glycoprotein considered to be a multifunctional protein present in the milk of many species and in other external secretions.
12) It consists of a single polypeptide chain protein organized as a bilobal structure, with the capacity to bind one iron atom in each of the two lobes. Lactoferrin with a high a percentage of molecules saturated with iron is known as holo-lactoferrin, and with a low content of iron, as apo-lactoferrin. 13) Lactoferrin is used as a functional component in certain products, 14) including infant milk formulas, yogurt, milk, dietary supplements, and pet supplements. [15] [16] [17] The main problem with supplemented products is the heat treatment that must be applied to them during technological processing, decreasing or inactivating completely the activity of lactoferrin.
Taking into account that it is not possible to use human milk lactoferrin as a component of products, bovine milk is the only source of this protein for commercial uses. However, is still unproven whether the activity of bovine lactoferrin (bLF) is the same as that of human lactoferrin (hLF) for all proposed functions. In contrast, there is evidence that bLF is markedly different from hLF in several respects. It has been observed that bLF does not bind to the same site as hLF on enterocytes in the infant small intestine. 18) Furthermore, the heat resistance of human lactoferrin is considerably higher than that of bovine lactoferrin. 10, 19) Hence it might be very interesting to replace bLF with human recombinant lactoferrin in certain special products for human consumption. There have been numerous attempts to produce recombinant human lactoferrin (rhLF), as summarized in a review by Conesa et al. 20) Only a few companies are producing rhLF on an industrial scale: rhLF from Aspergillus awamori, produced by Agennix (Houston, TX), rhLF from rice by Ventria Bioscience (Sacramento, CA), and rhLF from transgenic cows, by Pharming (Leiden, Netherlands).
The effects of heat treatment on milk proteins have been studied extensively over the last 50 years, but highpressure induced changes in milk proteins have become of interest only over the past 15 years. Despite the novelty of this research area, considerable progress has been made in identifying and characterizing highpressure induced changes in milk proteins. High hydrostatic pressure (HHP) induces protein denaturation by impairing the equilibrium among the interactions that stabilize the folded conformations of native proteins. 21) Protein compressibility is dependent on the compression of internal cavities, and this is related to internal packing. Application of HHP induces local or global changes in protein structure and finally can lead to denaturation. 22) Even though it is well known that high pressure can result in the denaturation and gelatinization of proteins, the mechanisms involved in these changes are poorly understood. 23) Although considerable information is available on the effects of HHP on milk proteins, particularly on whey proteins as isolated proteins and model systems, as far as we know, no data have been reported on the effects of HHP on lactoferrin. Hence the objective of this study was to investigate the effects of HHP on the structure of rhLF by fluorescence, immunoreactivity, and calorimetric studies, and also on its iron-binding and antibacterial activity.
Materials and Methods
Sample preparation. Recombinant human lactoferrin obtained from rice (rhLF) was kindly provided by Ventria Bioscience (Sacramento, CA). It was supplied in three forms: apo (0.05 mg of Fe/g of LF), holo (1.3 mg of Fe/g of LF), and As isolated from rice, or AsIs (0.98 mg of Fe/g of LF). These proteins were analyzed by SDS-polyacrylamide gel electrophoresis, which showed a main band that corresponded to a protein with molecular mass of 80 kDa. Hence they were used in the experiments without further purification. The samples for HHP treatment were prepared at a concentration of 2 mg/mL using three different diluents, a buffer containing 15 mM potassium phosphate, and 150 mM NaCl, pH 7.4 (phosphate-buffered saline, PBS), bovine whey, and skimmed milk.
High-pressure processing. Samples of lactoferrin at a concentration of 2 mg/mL were introduced into 2.5-mL polyethylene vials, eliminating headspace, and the vials were introduced in polyethylene bags that were filled with water and heat-sealed before pressurization. Protein was pressurized using a HHP apparatus model FPG 11500.B, Stansted Fluid Power (Stansted, Essex, UK), with water as transmitting medium. The pressure was raised to the desired value, 400, 500, or 650 MPa, and maintained for 15 min. The temperature of the sample was controlled by circulating water at 20 C through a jacket surrounding the pressure vessel. High-pressure treatments were performed in duplicate on different days. After high-pressure treatment, the samples were kept refrigerated at 4 C until analyzed within the following 48 h.
Fluorescence spectroscopy. Lactoferrin samples after HHP treatment were diluted in PBS at a concentration of 0.1 mg/mL. This concentration was estimated by spectrophotometry at A 280 , assuming the same extinction coefficient as that of human lactoferrin (extinction coefficients: apo-LF, " 24) Fluorescence spectra were acquired at 20 C on a spectrofluorimeter Aminco SLM 4800C (Rochester, NY) with a thermo-regulated cell holder. Samples of rhLF were placed in 1.0 cm cuvettes versus a blank of buffer, and fluorescence quenching spectra were obtained at excitation and emission wavelengths of 290 nm and 300-400 nm respectively. DSC analysis. Samples of rhLF after HHP treatment were concentrated using a centrifugal ultrafiltration device with a nominal molecular mass limit of 3 kDa (Amicon Ultra-15 3K, Billerica, MA). Lactoferrin samples were centrifuged at 4;000 Â g at 4 C to a concentration of 100 mg/mL as estimated by spectrophotometry. Samples and references (10 mL) were introduced into aluminium pans (TA Instruments, New Castle, DE) and sealed for analysis. The reference pans consisted of the same volume of PBS. DSC of lactoferrin samples was performed in a DuPont thermal analyzer (Model DSC 10, Neu-Isenburg, Germany), using a thermal analyst 2000 system. DSC scans were programmed in a temperature range of C at a heating rate of 10 C/min. Samples were analyzed at least in triplicate.
ICP-AES analysis. Ultrafiltration was used to separate any ferric ions that might have been released from rhLF during HHP treatment. Solutions of rhLF-AsIs and rhLF-holo (4 mL) after treatment were centrifuged using an ultrafiltration device with a nominal molecular mass limit of 3 kDa (Amicon Ultra-15 3K, Billerica, MA) at 4;000 Â g for 40 min at 4 C. Volumes of 2 mL of PBS were added consecutively to the protein concentrate, and this procedure was repeated 4 times. The filtrate (10 mL) was supplemented with nitric acid to achieve a 2% acid concentration, and the ferric ion content was determined by inductively coupled plasma-optical emission spectrometry (Thermo Elemental IRIS Intrepid ICP-AES, Radial Spectrometer, Thermo Electron, Waltham, MA). Samples of rhLF not subjected to ultrafiltration were also analyzed by ICP-OES to determine the total iron bound to each type of lactoferrin. ICP-AES analyses were conducted in duplicate.
Spectrophotometric assay. The iron saturation ability of apo rhLF after HHP treatment was determined by the addition of 5 mL of 2 mM Fe 3þ as FeNTA solution. The absorbance of the solution at 465 nm increased with iron addition until complete saturation. Lactoferrin was subjected to thermal treatment including 72 C for 15 s and 85 C for 2 min to compare the effects of high pressure and thermal treatment.
Noncompetitive ELISA assay. rhLF-AsIs was used as immunogen to obtain antisera in rabbits by the method of Conesa et al. 25) in order to develop a non-competitive ELISA assay. All procedures were carried out under Project Licence PI48/10 and were approved by the Ethics Committee for Animal Experiments of the University of Zaragoza. The care and use of animals followed the Spanish Policy for Animal Protection RD1201/05, which meets European Union Directive 86/ 609 on the protection of animals used for experimental and other scientific purposes.
ELISA intended to determine rhLF concentrations was performed according to the procedure for bovine lactoferrin by Franco et al., 17) as follows: Specific anti-rhLF antibodies were obtained by immunoadsorption using a column with rhLF insolubilized in Sepharose-4B (Sigma, St. Louis, MO) (5 mg of protein/mL of gel). Antibodies were concentrated and frozen at À20 C until use. The purified antilactoferrin antibodies were conjugated with peroxidase as described by Catty and Raykundalia. 26) Non-competitive sandwich ELISA to determine rhLF concentrations was developed through the following steps: The wells were coated with specific anti-rhLF antibodies (20 mg/mL) in 15 mM Na 2 CO 3 , 35 mM HNaCO 3 buffer pH 9.6 overnight at 4 C. The wells were then washed with a 1.5 mM KH 2 PO 4 , 8 mM Na 2 HPO 4 , 3 mM KCl, 0.1 M NaCl solution (PBS; pH 7.4) containing 0.05% Tween 20, and blocked with 3% ovalbumin in PBS for 2 h at room temperature. They were washed again, and the samples and rhLF standards (10, 50, 100, 250, 500, 750, and 1,000 ng/mL) were added to wells, and this was incubated for 1 h. The plate was then washed and specific anti-LFb antibodies conjugated with peroxidase at a dilution of 1:200,000 were added to wells, and this was incubated for 1 h. The plate was washed again and peroxidase substrate 3,3 0 ,5,5 0 -tetramethylbenzidine (ZEUInmunotec, Zaragoza, Spain) was added, and this was incubated for 30 min. Finally, 2 M H 2 SO 4 was added to stop the enzymatic reaction. The absorbance was measured at 450 nm using plate reader equipment (Multiskan MS, Labsystem, Helsinki, Finland).
Microbiological assays. E. coli O157:H7 CECT 4267 (Colección Española de Cultivos Tipo, Universidad de Valencia, Spain) was used to study the antimicrobial activity of rhLF after HHP treatment. All cultures were stored in skim milk at À20 C. Working cultures were obtained by transferring a loop of stock culture into 10 mL of tryptic soy broth (TSB), incubating this overnight, and transferring a loop to tryptic soy agar (TSA). After overnight incubation, an isolated colony was transferred to 10 mL of TSB, and this incubated at 37 C for 16-20 h. These cultures were used in the antimicrobial assays, which were carried out in microtiter plates. E. coli O157:H7 suspension in TSB was diluted in 1% sterile peptone water to achieve 10 4 -10 5 CFU/mL. A volume of 100 mL of diluted bacteria was added to the wells of a 96-well plate with 100 mL of lactoferrin solutions in the three different media, PBS, whey, or skim milk, to a final concentration of 1 mg/mL. The plates were incubated at 37 C for 24 h, and appropriate dilutions were made from the samples of the wells using sterile peptone water (1%) and spread on tryptic soy agar (TSA), and this was incubated at 37 C for 24 h.
Results
The thermal properties of rhLF after HHP treatment were studied by DSC using a heating rate of 10 C/min. A typical thermogram is presented in Fig. 1 . The results for DSC analysis for lactoferrin with different degrees of iron saturation after HHP treatment are shown in Table 1 . The heat resistance of the three forms of lactoferrin after HHP treatment was compared with reference to the main peak of the endotherms. There were no differences in the values of the maximum denaturation temperature (T m ), of about 72 C, for the main peak of rhLF-apo treated at 400 and at 500 MPa, as compared with the reference value. Samples of rhLFapo subjected to 400 and 500 MPa did not show marked differences in the enthalpy change of denaturation with respect to the reference value. However, when the HHP treatment applied was at 650 MPa, no endothermic peak was obtained for rhLF-apo, which indicates total denaturation of the protein. The main peaks of rhLFAsIs and rhLF-holo showed values of T m between 93.5 and 94.0 C after the proteins were subjected to various pressures, similarly to the reference value of the nontreated forms of lactoferrin. However, the values for denaturation enthalpy for the rhLF-AsIs were 20% lower than the reference values when the protein was treated at 400 and at 500 MPa, and decreased to 50% after treatment at 650 MPa. A minor peak appeared in the endotherms of the rhLF-AsIs, with a T m of about 75 C after 400 and 500 MPa treatment, a value that increased to 85 C when 650 MPa treatment was applied. The main peak obtained for rhLF-holo showed a reduction in denaturation enthalpy in the HHP-treated samples from 35 to 60% respect to the reference value, and a minor peak appeared when 650 MPa treatment was applied with a T m of 82 C. The conformational change in lactoferrin after HHP was studied by measuring the intrinsic fluorescence emission of tryptophan. The data obtained are presented Scanning was performed at a heating rate of 10 C/min. The main parameters obtained were peak maximum temperature (T m ) and enthalpy (ÁH). Table 1 . DSC Thermal Parameters Obtained in the Denaturation of rhLF from Rice, after HHP Treatment at 20 C The heating rate was 10 C/min. Each value represents the mean AE SD for three or four replicates. in Table 2 . Recombinant human lactoferrin exhibited an emission maximum wavelength ( max ) of between 335 and 338 nm for the three types of iron-saturated forms (apo, AsIs, and holo). The lactoferrin samples did not show differences in max after HHP treatment with respect to the non-treated protein. There was a decrease in the maximum of fluorescence intensities of the treated samples related to the increase in the pressure applied, the decrease being greater for rhLF-apo than for rhLFholo. However, the fluorescence intensity decreased in the rhLF-AsIs when HHP treatment at 400 MPa was applied, and then the value did not significantly change at higher pressures. The iron retention capacity of AsIs and holo lactoferrin after HHP treatment were determined by ICP-AES. Iron was not detected in the aqueous phase of any of the treated samples after ultrafiltration. Hence HHP treatment at 400, 500, and 650 MPa, did not appear to produce release of the iron bound to rhLF. In relation to the iron saturation capacity (Fig. 2) there was similar behavior as between the apo protein subjected to thermal treatment for 15 s at 72 C and that treated at 400 MPa, and the two proteins partially kept their iron-binding capacity. However, when pressure treatment was increased to 500 MPa or the temperature to 85 C, there was a complete loss of the iron-binding capacity of the protein.
Lactoferrin immunoreactivity was determined by ELISA after HHP treatment in various media (PBS, whey, and milk). The results are shown in Fig. 3a-c . The percentage of immunoreactive lactoferrin with respect to the non-treated protein after applying 400 MPa treatment (Fig. 3a) was relatively high for the three forms of rhLF (apo, AsIs, and holo), except for the rhLF-apo in milk, which showed values about 70% of the concentration measured in the control. When the pressure was increased to 500 MPa (Fig. 3b) , the immunoreactivity of the AsIs and holo forms remained constant, and there was a slight increase above 100% when the protein was treated in PBS or milk. However, the immunoreactivity of rhLF-apo decreased in all the treatment media, by 20% when the protein was treated in PBS, and more than 60% when it was treated in whey or milk. The immunoreactivity of lactoferrin was almost completely lost for the AsIs and holo forms under treatment at 600 MPa (Fig. 3c) , while for rhLF-apo in PBS and whey, the immunoreactivity remained at about 50% as compared to control. A decrease in immunoreactivity higher than 90% was found for rhLF-AsIs and holo after treatment at 600 MPa in the three different media. The antibacterial activity against E. coli O157:H7 of rhLF in the three iron saturation forms at 2 mg/mL after 400 and 500 MPa HHP treatments was studied. The antibacterial activity of rhLF-apo was observed in the three different media (PBS, whey, and milk), and showed reductions of approximately 9 log cycles of UFC/mL (Fig. 4a) . No antibacterial effect was exerted by rhLF-AsIs or rhLF-holo in either of the media tested. After treatment at 400 MPa, rhLF-apo maintained the same antibacterial activity as the non-treated protein.
However, when the pressure applied to rhLF-apo increased to 500 MPa, its antibacterial activity was lost (Fig. 4b) .
Discussion
The apparent maximum temperature of denaturation and the change in denaturation enthalpy are the main parameters obtained by DSC analysis that indicate the thermal stability of a protein. The results obtained in this study indicate that HHP treatments have an effect on the thermal parameters obtained by DSC for recombinant human lactoferrin, depending on the treatment. Increases in pressure intensity affect the conformation of rhLFapo. While there is no effect at an intermediate intensity treatment of 400 MPa or 500 MPa, complete denaturation is observed at 650 MPa. Some whey proteins, including -lactoglobulin and BSA, contain one buried free thiol group that can interact to form new disulfide bonds after heat treatment, 27) and this has been also observed for HHP. 28, 29) If -lactoglobulin is in an unfolding environment, under high pressure, the free SH group of Cys121 appears to be able to interact irreversibly with disulfide bonds. 30) However, this is not the case of lactoferrin, which does not have a free thiol group in the molecule. 31) The existence of a single peak in DSC thermograms indicates the same thermosensitivity and simultaneous denaturation of the two lobes of lactoferrin. 32) In this study, we observed that AsIslactoferrin was affected by the intermediate HHP treatment applied and was more resistant to higher pressure. A similar behavior has been found for the holo form of lactoferrin. In the thermogram of the holo lactoferrin a minor peak at 82 C appears, similar to that found in a previous study.
32) It might be due to the presence of aggregated molecules. The different conformation of the lactoferrin molecule due to the iron bound to it might be the reason for the difference in thermoresistance under intermediate HPP treatment. Since the holo form is more compact than the apo form, it might have a different response to the intensity of HHP treatment.
Fluorescence spectroscopy is an analytical technique that is used to obtain information about the molecular environment in the vicinity of the functional fluorophore groups of proteins. 33) Three main amino acid residues contribute to fluorescence, tryptophan, tyrosine, and phenylalanine, the maximum excitation wavelength for tryptophan in water being 350 nm. 34) Human lactoferrin contains 11 tryptophan/mol, 35, 36) and hence recombinant human lactoferrin from rice can be also considered to bear 11 residues, because its sequence and tridimensional structure are the same as those of milk lactoferrin, as obtained by crystallography. 37) In general, the intensity of fluorescence of the three forms of lactoferrin decreases following the sequence apo > native > holo. The higher fluorescence found for the apo form indicates a substantial change in the conformation of the protein to a more hydrophobic conformation, favored by the absence of iron. This effect has been observed also for -lactalbumin, because when the calcium bound to the native form of the protein was removed, the intensity of fluorescence increased. 38) These differences between the two forms of lactoferrin were also observed in a kinetic study of iron removal from bovine lactoferrin by EDTA, in which the increase in the intensity of fluorescence was used to measure the degree of iron removal. 39) The decrease in the intensity of maximum fluorescence reflects a conformational change in lactoferrin and corresponds to a decrease in solvent polarity that might be due to increased quenching of some tryptophan residues. As far as we know, there are no published data on the effect of HHP on rhLF, though some studies on hLF and its thermal properties have been published. 40, 41) Structural analysis of human lactoferrin as compared with serum transferrin, including fluorescence measurements have been done by others. 40) They reported a maximum emission wavelength for apo-lactoferrin in 0.05 M Tris-HCl buffer pH 7.6 of 334 nm, similar to that found in the present study. It has been reported 41) that lactoferrin denatured by urea addition showed a maximum emission wavelength of 355 nm, indicating complete exposure of tryptophan residues.
The results of the present study indicate that the fluorescence parameters of lactoferrin treated by high pressure are not related in all cases to the DSC parameters, as has been observed by others in a similar study of the effects of heat treatment at different pHs on lactoferrin fluorescence. 42) It is accepted that calorimetry and tryptophan fluorescence reflect changes in the conformation of proteins, but do not measure precisely the same parameters. When a protein treated at high pressure is subjected to DSC, the heat flow breaks the bonds that maintain its structure, causing denaturation and in some cases aggregation, but the intensity of fluorescence reveals the movement of tryptophan residues from the inner part of the protein to the surface.
In the present study, no release of iron was detected from the native (AsIs) and iron-saturated (holo) forms of rhLF after subjection of them to HHP treatments of 400, 500, and 650 MPa for 15 min. As far as we know, no data on the effect of HHP on iron release from lactoferrin have been published, but an investigation of the use of pulse electric field treatment (PEF) on lactoferrin 43) indicated that PEF did not affect the retention of iron when bovine lactoferrin was treated in an environment of low ionic strength. Those also applied various heat treatments, and found that at 72 C for 15 s, there was little release of iron from lactoferrin in its native form, and that at 90 C for 10 min over 20% of bound iron was released. These results have been corroborated by other studies, 44) which reported 15-30% loss of the iron-binding capacity of bovine lactoferrin in its native form after heating at 90 C for 4 min. The results of this study indicate that there is a partial loss of the iron saturation capacity of lactoferrin under low pressure treatment, and a complete loss under higher pressure. This suggests that a conformational change takes place in the structure of lactoferrin molecule, related to the effect of the treatment on the iron-binding sites. Some investigations have found that the ironbinding site of the N-lobe in the apo form of lactoferrin is the first site to bind iron, because it has a more open conformation than the C-lobe, allowing easy access to iron coming from the medium or from an iron complex. 45) It is possible that the more intense treatments under high pressure change the conformation of the iron-binding sites in the lobes of lactoferrin, affecting its iron capacity.
The results found for lactoferrin immunoreactivity after HHP treatment as determined by ELISA indicated no effect of 400 MPa treatment on the three types of media used, PBS, whey, and milk. When the intensity of treatment increased to 500 MPa, an approximately 80% loss of immunoreactivity was found for the recombinant human protein in the apo form in the milk and whey, holo-lactoferrin being the form most resistant to HHP treatment. Higher heat resistance has been observed when -lactalbumin and lactoferrin were treated in PBS compared to milk. 46, 47) This can be attributed to a decrease in milk pH with heating that does not occur in phosphate buffer. Furthermore, high pressure treatment might induce the formation of interactions between milk proteins what can be established in higher degree in the apo form of lactoferrin, as its conformation is more open than that of the holo or AsIs forms. Those interactions might interfere in the immunoreactivity of lactoferrin, which would explain the results observed in our study. The effects of heat treatment of whey proteins (-lactoglobulin, -lactalbumin, lactoperoxidase, IgG, and lactoferrin) was previously studied by our group, and it was found that pasteurization did not affect the immunoreactivity of the proteins, while high-temperature treatment (80-90 C) for short periods produced distortion of all whey proteins with the exception of -lactalbumin. 48) In that study, the degree of denaturation increased with temperature and changed with the saturation of the protein. Lactoferrin showed a marked decrease in immunoreactivity when it was treated with whey.
One of the main properties of lactoferrin as to its application is the antibacterial activity that has been found to occur in some organisms through adsorption to the bacterial surface. It has been found that this interaction is specific for many of them, including E. coli and other members of the Enterobacteriaceae family. 49, 50) The increasing demand for natural antimicrobials makes necessary further research on the stability and antibacterial activity of compounds such as lactoferrin that are naturally present in certain food products. Since 1982, E. coli O157:H7 has been associated with food poisoning due to the consumption of undercooked meat, raw milk, apple juice, yogurt, water, and fresh salads.
51) The findings of our study indicate that only the recombinant human lactoferrin from rice in its apo form shows antibacterial activity against E. coli O157:H7, while the other forms of the protein, holo and AsIs, do not inhibit the growth of E. coli. 52) 400 MPa treatment of apo rhLF does not diminish its antibacterial activity, though the samples lost their inhibitory activity after treatment at 500 MPa.
The data obtained here should contribute to evaluation of the adequacy of non-thermal treatments to preserve the functional properties of human recombinant lactoferrin to be used as a component in functional products. It is also very important to maintain the antibacterial activity of recombinant lactoferrin when it is to be applied in hurdle technology, a preservation method that consists in using several factors or ''hurdles'' that inhibit bacterial growth at low doses or low intensity.
